icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
mHveCSYpGt22WZ67
Listen
